Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04622150 · ClinicalTrials.gov registry record · NA
Effectiveness RCT of Customized Adherence Enhancement
A NA study of Bipolar Disorder, sponsored by Case Western Reserve University.
- Active
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 3
- Study locations
NCT04622150 is a NA study of Bipolar Disorder that is active but no longer recruiting, run by Case Western Reserve University. The registered enrollment target is 190 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (43% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04622150, a NA study of Bipolar Disorder, is active but no longer recruiting, sponsored by Case Western Reserve University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 3
- Study locations
Study Summary
Approximately one in two individuals with bipolar disorder (BD) are non-adherent with medication, often leading to severe and negative consequences. Unfortunately, there is no widely used evidence-based approach to target poor adherence among individuals with BD. Building upon positive efficacy trial results, the proposed project will test the effectiveness of technology-facilitated Customized Adherence Enhancement (CAE) vs. enhanced treatment as usual (eTAU) using a prospective randomized controlled design in public mental health care settings and preferentially enrolling poorly adherent/high-risk individuals with BD. Deliverables include a curriculum-driven adherence enhancement approach that can be implemented in public healthcare settings and which can improve outcomes for the most vulnerable groups of people with BD.
Conditions Studied
Interventions
- BEHAVIORAL Customized Adherence Enhancement (CAE)
- BEHAVIORAL Enhanced Treatment as Usual (eTAU)
Study Locations (3)
Ohio
- W.O. Walker Center - Cleveland
- MetroHealth Medical Center - Cleveland
- The Nord Center - Lorain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04622150
The ClinicalTrials.gov registry entry for NCT04622150 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (43% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Customized Adherence Enhancement (CAE) is the first listed.
NCT04622150 reports 3 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04622150 about?
NCT04622150 is a clinical study titled "Effectiveness RCT of Customized Adherence Enhancement". Approximately one in two individuals with bipolar disorder (BD) are non-adherent with medication, often leading to severe and negative consequences. Unfortunately, there is no widely used evidence-based approach to target poor adherence among individuals with BD. Building upon positive efficacy tria...
What is the current status of trial NCT04622150?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2022-02-01. Estimated completion is 2026-06-01.
What conditions does trial NCT04622150 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT04622150?
The interventions under investigation include: Customized Adherence Enhancement (CAE) (BEHAVIORAL), Enhanced Treatment as Usual (eTAU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04622150?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04622150 being conducted?
This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.